source
- Aura Biosciences cuts 20% of staff and reshuffles C-suite to focus on ocular oncologyAura Biosciences announced it is eliminating about one-fifth of its workforce as part of a broader restructuring under its new chief executive officer, Natalie Holles, who took the helm in April.…
- FDA rejects ITM radiopharma therapy while WHO defends immunization schedulesThe U.S. Food and Drug Administration has issued a rejection of a radiopharmaceutical therapy identified as ITM, indicating that the product did not meet the agency's requirements for approval. Th…